Propofol is used to put patients to sleep before surgery and medical procedures, and to keep them sedated while on a ventilator in the hospital. It works quickly to make someone unconscious and is commonly used by anesthesiologists.[2] Diprivan is currently approved and in use across 146 indications[4].[1]
Diprivan is one of 1947 small molecule programs targeting Glioma. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Application
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
2828 competitors in Breast Cancer
Diprivan
Tykerb
Trodelvy
Lexiscan
Voltaren
Spravato
Cortef
Aquasol E
Paracetamol
Vit D
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Oct 2, 1989
DIPRIVAN
NDA NDA019627
Sources
Details